Feedback / Questions
ANB033 - AnaptysBio
rosnilimab (ANB030) - AnaptysBio
ANB101 - AnaptysBio
https://www.globenewswire.com/news-release/2025/09/29/3158108/0/en/Anaptys-Announces-Intent-to-Separate-Biopharma-Operations-from-Substantial-Royalty-Assets-by-Year-end-2026.html
Sep 29, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next